{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:39:10Z","timestamp":1785213550317,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteogenesis Imperfecta (OI) is characterised by bone fragility. Among several features, easy bruising and multiple case reports on haemorrhagic events have been reported. This paper describes the diverse manifestations of bleeding and bruising in a large cohort of 328 OI patients. The aim of this study is to provide insight in the diverse aspects and therapeutic considerations of bleedings in OI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This descriptive cohort study was conducted at the National Expert Center for adults with OI in the Netherlands. Bleeding was assessed by the validated self-bleeding assessment tool (Self-BAT) The tool was distributed among 328 adults with different clinically confirmed types of OI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>195 of 328 invited patients (completion rate 60%) with OI type 1 (n\u2009=\u2009144), OI type 3 (n\u2009=\u200917) and OI type 4 (n\u2009=\u200934), aged between 18 and 82\u00a0years, completed the tool. Self-BAT scores were above the normal range in 42% of all patients. For males Self-BAT scores were increased in 37% with a mean score of 3.7, ranged between 0 and 18. For females the Self-BAT scores were increased in 44% with a mean of 5.4 and a range of 0\u201324. No statistical differences in OI subtypes were found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Bleeding tendency appears to be a relevant complication in OI patients as this study confirms the presumption of bleeding tendency. There are specific recommendations to clinicians who treat OI patients to consider an assessment of bleeding tendency and use potential interventions to reduce haemorrhagic complications and improve quality of life.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03054-8","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:02:29Z","timestamp":1707739349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bleeding assessment in a large cohort of patients with Osteogenesis Imperfecta"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7907-8887","authenticated-orcid":false,"given":"Koert","family":"Gooijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabri\u00ebla","family":"Heidsieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Harsevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Bout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus","family":"Janus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"issue":"8","key":"3054_CR1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00439-021-02302-2","volume":"140","author":"L Claeys","year":"2021","unstructured":"Claeys L, Storoni S, Eekhoff M, et al. Collagen transport and related pathways in Osteogenesis Imperfecta. Hum Genet. 2021;140(8):1121\u201341. https:\/\/doi.org\/10.1007\/s00439-021-02302-2.","journal-title":"Hum Genet"},{"issue":"8","key":"3054_CR2","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1542\/pir.31-8-e54","volume":"31","author":"SR Starr","year":"2010","unstructured":"Starr SR, Roberts TT, Fischer PR. Osteogenesis Imperfecta: primary care. Pediatr Rev. 2010;31(8):e54\u201364. https:\/\/doi.org\/10.1542\/pir.31-8-e54.","journal-title":"Pediatr Rev"},{"issue":"6","key":"3054_CR3","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","volume":"164","author":"FSS Van Dijk","year":"2014","unstructured":"Van Dijk FSS, Sillence DOO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014;164(6):1470\u201381. https:\/\/doi.org\/10.1002\/ajmg.a.36545.","journal-title":"Am J Med Genet A"},{"key":"3054_CR4","unstructured":"Steiner R, Adsit J, Basel D. COL1A1\/2-Related Osteogenesis Imperfecta. GeneReviews. doi:NBK1295 [bookaccession]"},{"key":"3054_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16097","author":"K Gooijer","year":"2019","unstructured":"Gooijer K, Rondeel JMM, van Dijk FS, Harsevoort AGJ, Janus GJM, Franken AAM. Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals. Br J Haematol. 2019. https:\/\/doi.org\/10.1111\/bjh.16097.","journal-title":"Br J Haematol"},{"issue":"5","key":"3054_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2009.06.001","volume":"23","author":"F Malfait","year":"2009","unstructured":"Malfait F, De PA. Bleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment. Blood Rev. 2009;23(5):191\u20137. https:\/\/doi.org\/10.1016\/j.blre.2009.06.001.","journal-title":"Blood Rev"},{"issue":"12","key":"3054_CR7","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1111\/jth.14310","volume":"16","author":"A Artoni","year":"2018","unstructured":"Artoni A, Bassotti A, Marinelli B, et al. Hemostatic abnormalities in patients with Ehlers\u2013Danlos syndrome. J Thromb Haemost. 2018;16(12):2425\u201331. https:\/\/doi.org\/10.1111\/jth.14310.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3054_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0002-9343(57)90016-5","volume":"22","author":"BM Siegel","year":"1957","unstructured":"Siegel BM, Friedman IA, Schwartz SO. Hemorrhagic disease in Osteogenesis Imperfecta Study of platelet functional defect. Am J Med. 1957;22(2):315\u201321.","journal-title":"Am J Med"},{"issue":"4","key":"3054_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1182\/blood.V39.4.500.500","volume":"39","author":"WE Hathaway","year":"1972","unstructured":"Hathaway WE, Solomons CC, Ott JE, Ott E. Platelet function and pyrophosphates in osteogenesis imperfecta. Blood. 1972;39(4):500\u20139.","journal-title":"Blood"},{"issue":"6","key":"3054_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7326\/0003-4819-68-6-1237","volume":"68","author":"JW Estes","year":"1968","unstructured":"Estes JW. Platelet size and function in the heritable disorders of connective tissue. Ann Intern Med. 1968;68(6):1237\u201349.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3054_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1600-0609.1984.tb02393.x","volume":"33","author":"SA Evensen","year":"1984","unstructured":"Evensen SA, Myhre L, Stormorken H. Haemostatic studies in osteogenesis imperfecta. Scand J Haematol. 1984;33(2):177\u20139. https:\/\/doi.org\/10.1111\/j.1600-0609.1984.tb02393.x.","journal-title":"Scand J Haematol"},{"issue":"8","key":"3054_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/jth.13368","volume":"14","author":"J Boender","year":"2016","unstructured":"Boender J, Kruip MJHA, Leebeek FWG. A diagnostic approach to mild bleeding disorders. J Thromb Haemost. 2016;14(8):1507\u201316. https:\/\/doi.org\/10.1111\/jth.13368.","journal-title":"J Thromb Haemost"},{"key":"3054_CR13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1104544","author":"J Pereira","year":"2008","unstructured":"Pereira J, Quiroga T, Mezzano D. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Semin Thromb Hemost. 2008. https:\/\/doi.org\/10.1055\/s-0028-1104544.","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"3054_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1538-7836.2007.02520.x","volume":"5","author":"F Rodeghiero","year":"2007","unstructured":"Rodeghiero F, et al. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost. 2007;5(11):157\u201366.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3054_CR15","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1111\/hae.12747","volume":"21","author":"M Deforest","year":"2015","unstructured":"Deforest M, Grabell J, Albert S, et al. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia. 2015;21(5):e384\u20138. https:\/\/doi.org\/10.1111\/hae.12747.","journal-title":"Haemophilia"},{"issue":"04","key":"3054_CR16","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1055\/s-0039-3400483","volume":"03","author":"MC Punt","year":"2019","unstructured":"Punt MC, Blaauwgeers MW, Timmer MA, Welsing PMJ, Schutgens REG, van Galen KPM. Reliability and feasibility of the self-administered ISTH-bleeding assessment tool. TH Open. 2019;03(04):e350\u20135. https:\/\/doi.org\/10.1055\/s-0039-3400483.","journal-title":"TH Open."},{"issue":"9","key":"3054_CR17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","volume":"8","author":"F Rodeghiero","year":"2010","unstructured":"Rodeghiero F, Tosetto A, Abshire T, et al. ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063\u20135. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03975.x.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"3054_CR18","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1111\/j.1538-7836.2012.04923.x","volume":"10","author":"N Rydz","year":"2012","unstructured":"Rydz N, James PD. The evolution and value of bleeding assessment tools. J Thromb Haemost. 2012;10(11):2223\u20139. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04923.x.","journal-title":"J Thromb Haemost"},{"key":"3054_CR19","first-page":"1","volume":"8","author":"F Rodeghiero","year":"2011","unstructured":"Rodeghiero F, Tosetto A, Abshire T, et al. ISTH BAT: supplementary material to the official communication of the SSC. J Thromb Haemost. 2011;8:1\u201321.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"3054_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/hae.12503","volume":"20","author":"M Elbatarny","year":"2014","unstructured":"Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831\u20135. https:\/\/doi.org\/10.1111\/hae.12503.","journal-title":"Haemophilia"},{"issue":"1","key":"3054_CR21","first-page":"47","volume":"78","author":"I Oakley","year":"2010","unstructured":"Oakley I, Reece LP. Anesthetic implications for the patient with osteogenesis imperfecta. AANA J. 2010;78(1):47\u201353.","journal-title":"AANA J"},{"issue":"26","key":"3054_CR22","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1182\/blood-2014-02-557264","volume":"123","author":"AB Federici","year":"2014","unstructured":"Federici AB, Bucciarelli P, Castaman G, et al. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood. 2014;123(26):4037\u201344. https:\/\/doi.org\/10.1182\/blood-2014-02-557264.","journal-title":"Blood"},{"issue":"4","key":"3054_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00000542-200210000-00039","volume":"97","author":"MT Keegan","year":"2002","unstructured":"Keegan MT, Whatcott BD, Harrison BA. Osteogenesis imperfecta, perioperative bleeding, and desmopressin. Anesthesiology. 2002;97(4):1011\u20133. https:\/\/doi.org\/10.1097\/00000542-200210000-00039.","journal-title":"Anesthesiology"},{"issue":"5","key":"3054_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1055\/s-0028-1108437","volume":"95","author":"U Langness","year":"1970","unstructured":"Langness U, Behnke H. Klinik und Genetik der Osteogenesis imperfecta*. Dtsch Med Wochenschr. 1970;95(5):209\u201312. https:\/\/doi.org\/10.1055\/s-0028-1108437.","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"3054_CR25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/0003-4975(95)00706-Q","volume":"60","author":"RS Wong","year":"1995","unstructured":"Wong RS, Follis FM, Shively BK, Wernly JA. Osteogenesis imperfecta and cardiovascular diseases. Ann Thorac Surg. 1995;60(5):1439\u201343. https:\/\/doi.org\/10.1016\/0003-4975(95)00706-Q.","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"3054_CR26","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/pan.13504","volume":"28","author":"L Rothschild","year":"2018","unstructured":"Rothschild L, Goeller JK, Voronov P, Barabanova A, Smith P. Anesthesia in children with osteogenesis imperfecta: retrospective chart review of 83 patients and 205 anesthetics over 7 years. Paediatr Anaesth. 2018;28(11):1050\u20138. https:\/\/doi.org\/10.1111\/pan.13504.","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"3054_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/hrt.35.1.103","volume":"35","author":"SJ Wood","year":"1973","unstructured":"Wood SJ, Thomas J, Braimbridge MV. Mitral valve disease and open heart surgery in osteogenesis imperfecta tarda. Br Heart J. 1973;35(1):103. https:\/\/doi.org\/10.1136\/hrt.35.1.103.","journal-title":"Br Heart J"},{"key":"3054_CR28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.72.3.363","author":"DD Waters","year":"1977","unstructured":"Waters DD, Clark DW, Symbas PN, Schlant RC. Aortic and mitral valve replacement in a patient with osteogenesis imperfecta. Chest. 1977. https:\/\/doi.org\/10.1378\/chest.72.3.363.","journal-title":"Chest"},{"key":"3054_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/0266-4356(87)90144-6","author":"ME Morton","year":"1987","unstructured":"Morton ME. Excessive bleeding after surgery in osteogenesis imperfecta. Br J Oral Maxillofac Surg. 1987. https:\/\/doi.org\/10.1016\/0266-4356(87)90144-6.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"1","key":"3054_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF02722753","volume":"70","author":"RK Mondal","year":"2003","unstructured":"Mondal RK, Mann U, Sharma M, Mondal RK, Mann U, Sharma M. Osteogenesis imperfecta with bleeding diathesis. Indian J Pediatr. 2003;70(1):95\u20136. https:\/\/doi.org\/10.1007\/BF02722753.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"3054_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00003643-199703000-00017","volume":"14","author":"G Edge","year":"1997","unstructured":"Edge G, Okafor B, Fennelly ME, Ransford AO. An unusual manifestation of bleeding diathesis in a patient with osteogenesis imperfecta. Eur J Anaesthesiol. 1997;14(2):215\u20139.","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"3054_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ajmg.a.32653","volume":"149A","author":"E Faqeih","year":"2009","unstructured":"Faqeih E, Roughley P, Glorieux FH, Rauch F. Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2. Am J Med Genet A. 2009;149A(3):461\u20135. https:\/\/doi.org\/10.1002\/ajmg.a.32653.","journal-title":"Am J Med Genet A"},{"issue":"02","key":"3054_CR33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S0003-4975(02)03700-1","volume":"74","author":"M Kastrup","year":"2002","unstructured":"Kastrup M, von Heymann C, Hotz H, et al. Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg. 2002;74(02):910\u20132. https:\/\/doi.org\/10.1016\/S0003-4975(02)03700-1.","journal-title":"Ann Thorac Surg"},{"issue":"5\u20136","key":"3054_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1515\/jpem-2012-0272","volume":"26","author":"CR Paterson","year":"2013","unstructured":"Paterson CR, Monk EA. Temporary brittle bone disease: association with intracranial bleeding. J Pediatr Endocrinol Metab. 2013;26(5\u20136):417\u201326. https:\/\/doi.org\/10.1515\/jpem-2012-0272.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"3054_CR35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","volume":"4","author":"JE Sadler","year":"2006","unstructured":"Sadler JE, Budde U, Eikenboom JCJ, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor. J Thromb and Haemost. 2006;4(10):2103\u201314. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02146.x.","journal-title":"J Thromb and Haemost"},{"issue":"2","key":"3054_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/hae.12811","volume":"22","author":"S Obaji","year":"2016","unstructured":"Obaji S, Alikhan R, Rayment R, Carter P, Macartney N, Collins P. Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and\/or desmopressin. Haemophilia. 2016;22(2):285\u201391. https:\/\/doi.org\/10.1111\/hae.12811.","journal-title":"Haemophilia"},{"issue":"3","key":"3054_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2015-010471","volume":"6","author":"T Kataoka","year":"2016","unstructured":"Kataoka T, Hoshi K, Ando T. Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study. BMJ Open. 2016;6(3):1. https:\/\/doi.org\/10.1136\/bmjopen-2015-010471.","journal-title":"BMJ Open"},{"key":"3054_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011930.pub3","author":"S Kumbargere Nagraj","year":"2018","unstructured":"Kumbargere Nagraj S, Prashanti E, Aggarwal H, et al. Interventions for treating post-extraction bleeding. Cochrane Database of Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD011930.pub3.","journal-title":"Cochrane Database of Syst Rev."},{"issue":"5","key":"3054_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejmg.2008.05.003","volume":"51","author":"I Bailleul-Forestier","year":"2008","unstructured":"Bailleul-Forestier I, Berdal A, Vinckier F, de Ravel T, Fryns JP, Verloes A. The genetic basis of inherited anomalies of the teeth. Part 2: syndromes with significant dental involvement. Eur J Med Genet. 2008;51(5):383\u2013408. https:\/\/doi.org\/10.1016\/j.ejmg.2008.05.003.","journal-title":"Eur J Med Genet"},{"issue":"5","key":"3054_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jormas.2020.03.003","volume":"121","author":"M Contaldo","year":"2020","unstructured":"Contaldo M, Luzzi V, Ierardo G, et al. Bisphosphonate-related osteonecrosis of the jaws and dental surgery procedures in children and young people with osteogenesis imperfecta: a systematic review. J Stomatol Oral Maxillofac Surg. 2020;121(5):556\u201362. https:\/\/doi.org\/10.1016\/j.jormas.2020.03.003.","journal-title":"J Stomatol Oral Maxillofac Surg."},{"issue":"3","key":"3054_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijgo.2014.09.027","volume":"128","author":"IS Fraser","year":"2015","unstructured":"Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynecol Obstet. 2015;128(3):196\u2013200. https:\/\/doi.org\/10.1016\/j.ijgo.2014.09.027.","journal-title":"Int J Gynecol Obstet"},{"key":"3054_CR42","unstructured":"National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management | Guidance. Nice guidelines"},{"key":"3054_CR43","doi-asserted-by":"publisher","unstructured":"Hayward CPM. Diagnosis and management of mild bleeding disorders. In Hematology\/the education program of the American society of hematology American society of hematology education program (2005). https:\/\/doi.org\/10.1182\/asheducation-2005.1.423","DOI":"10.1182\/asheducation-2005.1.423"},{"issue":"6","key":"3054_CR44","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/GCO.0b013e3282f1ddbe","volume":"19","author":"I El-Hemaidi","year":"2007","unstructured":"El-Hemaidi I, Gharaibeh A, Shehata H. Menorrhagia and bleeding disorders. Curr Opin Obstet Gynecol. 2007;19(6):S15\u201321. https:\/\/doi.org\/10.1097\/GCO.0b013e3282f1ddbe.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"9101","key":"3054_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)08248-2","volume":"351","author":"RA Kadir","year":"1998","unstructured":"Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351(9101):485\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(97)08248-2.","journal-title":"Lancet"},{"issue":"5","key":"3054_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1160\/TH11-03-0180","volume":"106","author":"EM de Wee","year":"2011","unstructured":"de Wee EM, Knol HM, Mauser-Bunschoten EP, et al. Gynaecological and obstetric bleeding in moderate and severe von willebrand disease. Thromb Haemost. 2011;106(5):885\u201392. https:\/\/doi.org\/10.1160\/TH11-03-0180.","journal-title":"Thromb Haemost"},{"issue":"2","key":"3054_CR47","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","volume":"145","author":"PA Kouides","year":"2009","unstructured":"Kouides PA, Byams VR, Philipp CS, et al. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol. 2009;145(2):212\u201320. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07610.x.","journal-title":"Br J Haematol"},{"key":"3054_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2393-9-55","volume":"9","author":"M Knight","year":"2009","unstructured":"Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the international postpartum hemorrhage collaborative group. BMC Pregnancy Childbirth. 2009;9:1\u201310. https:\/\/doi.org\/10.1186\/1471-2393-9-55.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"3054_CR49","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/jp.2016.111","volume":"36","author":"J Ruiter-Ligeti","year":"2016","unstructured":"Ruiter-Ligeti J, Czuzoj-Shulman N, Spence AR, Tulandi T, Abenhaim HA. Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study. J Perinatol. 2016;36(10):828\u201331. https:\/\/doi.org\/10.1038\/jp.2016.111.","journal-title":"J Perinatol"},{"issue":"4","key":"3054_CR50","doi-asserted-by":"publisher","first-page":"100362","DOI":"10.1016\/j.ajogmf.2021.100362","volume":"3","author":"R Rao","year":"2021","unstructured":"Rao R, Cuthbertson D, Nagamani SCS, et al. Pregnancy in women with osteogenesis imperfecta: pregnancy characteristics, maternal, and neonatal outcomes. Am J Obstet Gynecol MFM. 2021;3(4):100362. https:\/\/doi.org\/10.1016\/j.ajogmf.2021.100362.","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"1","key":"3054_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1471-0528.2004.00303.x","volume":"112","author":"WH Zhang","year":"2005","unstructured":"Zhang WH, Alexander S, Bouvier-Colle MH, Macfarlane A. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG. 2005;112(1):89\u201396. https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00303.x.","journal-title":"BJOG"},{"issue":"12","key":"3054_CR52","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1111\/j.1538-7836.2008.03168.x","volume":"6","author":"C Chauleur","year":"2008","unstructured":"Chauleur C, Cochery-Nouvellon E, Mercier E, et al. Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. J Thromb Haemost. 2008;6(12):2067\u201374. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03168.x.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"3054_CR53","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3109\/14767058.2014.937698","volume":"28","author":"N Buzaglo","year":"2015","unstructured":"Buzaglo N, Harlev A, Sergienko R, Sheiner E. Risk factors for early postpartum hemorrhage (PPH) in the first vaginal delivery, and obstetrical outcomes in subsequent pregnancy. J Matern Fetal Neonatal Med. 2015;28(8):932\u20137. https:\/\/doi.org\/10.3109\/14767058.2014.937698.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3054_CR54","doi-asserted-by":"publisher","unstructured":"Prevention and Management of Postpartum Haemorrhage: Green-top Guideline No. 52. BJOG. 2017;124(5). https:\/\/doi.org\/10.1111\/1471-0528.14178","DOI":"10.1111\/1471-0528.14178"},{"issue":"6","key":"3054_CR55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/hae.13846","volume":"25","author":"CSB Veen","year":"2019","unstructured":"Veen CSB, van der Reijken IS, Jansen AJG, et al. Severe postpartum haemorrhage as first presenting symptom of an inherited bleeding disorder. Haemophilia. 2019;25(6):1051\u20138. https:\/\/doi.org\/10.1111\/hae.13846.","journal-title":"Haemophilia"},{"issue":"10084","key":"3054_CR56","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"H Shakur","year":"2017","unstructured":"Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2017;389(10084):2105\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(17)30638-4.","journal-title":"The Lancet"},{"issue":"4","key":"3054_CR57","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/hae.13486","volume":"24","author":"FCJI Moenen","year":"2018","unstructured":"Moenen FCJI, Nelemans PJ, Schols SEM, Schouten HC, Henskens YMC, Beckers EAM. The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: a systematic review. Haemophilia. 2018;24(4):525\u201335. https:\/\/doi.org\/10.1111\/hae.13486.","journal-title":"Haemophilia"},{"key":"3054_CR58","doi-asserted-by":"publisher","unstructured":"Quiroga T, Mezzano D. Is my patient a bleeder? A diagnostic framework for mild bleeding disorders. In Hematology\/the education program of the American society of hematology American society of hematology education program. 2012;2012. https:\/\/doi.org\/10.1182\/asheducation.v2012.1.466.3798741","DOI":"10.1182\/asheducation.v2012.1.466.3798741"},{"issue":"12","key":"3054_CR59","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","volume":"3","author":"F Rodeghiero","year":"2005","unstructured":"Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005;3(12):2619\u201326. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01663.x.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3054_CR60","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/j.1538-7836.2010.03796.x","volume":"8","author":"TT Biss","year":"2010","unstructured":"Biss TT, Blanchette VS, Clark DS, et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost. 2010;8(5):950\u20136. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03796.x.","journal-title":"J Thromb Haemost"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03054-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03054-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03054-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:05:14Z","timestamp":1707739514000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03054-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03054-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of the Isala Hospital, Zwolle, The Netherlands, confirmed that the Medical Research Involving Human Subjects Act does not apply (reference number: 190513). All patients who were invited for this study signed an informed-consent form for study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}